Lv4
490 积分 2023-12-06 加入
Izalontamab brengitecan, an EGFR and HER3 bispecific antibody–drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China
23天前
已完结
艾瑞昔布的研发及应用进展
29天前
已完结
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
1个月前
已关闭
GPCR drug discovery: new agents, targets and indications
1个月前
已完结
Adopting GPR75 in treating obesity: unraveling the knowns and unknowns of this orphan GPCR
1个月前
已完结
Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non–Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA
2个月前
已完结
Prognostic Impact of LGR5, Prox1, and Notch1 Biomarkers in Stage II to III Colon Cancer
2个月前
已关闭
Phase 1 First-in-Human Dose-Expansion Study of The Oral SF3B1 Modulator H3B‑8800 In Lower-Risk Myelodysplastic Syndrome
2个月前
已完结
Recent Progress and Prospects of Small Molecules for NLRP3 Inflammasome Inhibition
3个月前
已完结
Discovery of DFV890, a Potent Sulfonimidamide-Containing NLRP3 Inflammasome Inhibitor
3个月前
已完结
皖公网安备34019202002308
